Related references
Note: Only part of the references are listed.ELECTRICAL IMPEDANCE MYOGRAPHY IN DUCHENNE MUSCULAR DYSTROPHY AND HEALTHY CONTROLS: A MULTICENTER STUDY OF RELIABILITY AND VALIDITY
Craig M. Zaidman et al.
MUSCLE & NERVE (2015)
ELECTROMYOGRAPHIC FINDINGS IN 37 PATIENTS WITH ADULT-ONSET ACID MALTASE DEFICIENCY
Charles D. Kassardjian et al.
MUSCLE & NERVE (2015)
CORRELATION BETWEEN QUANTITATIVE WHOLE-BODY MUSCLE MAGNETIC RESONANCE IMAGING AND CLINICAL MUSCLE WEAKNESS IN POMPE DISEASE
Jeffrey J. Horvath et al.
MUSCLE & NERVE (2015)
Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury
Stephen J. P. Pratt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Peripheral nerve and neuromuscular junction pathology in Pompe disease
Darin J. Falk et al.
HUMAN MOLECULAR GENETICS (2015)
Sustained Correction of Motoneuron Histopathology Following Intramuscular Delivery of AAV in Pompe Mice
Mai K. ElMallah et al.
MOLECULAR THERAPY (2014)
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy
Giancarlo Parenti et al.
MOLECULAR THERAPY (2014)
ELECTRICAL IMPEDANCE MYOGRAPHY FOR THE IN VIVO AND EX VIVO ASSESSMENT OF MUSCULAR DYSTROPHY ( mdx) MOUSE MUSCLE
Jia Li et al.
MUSCLE & NERVE (2014)
A Comparison of Three Electrophysiological Methods for the Assessment of Disease Status in a Mild Spinal Muscular Atrophy Mouse Model
Jia Li et al.
PLOS ONE (2014)
B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
M. Corti et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Phase I/II Trial of Adeno-Associated Virus-Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
Barbara K. Smith et al.
HUMAN GENE THERAPY (2013)
Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle
Romain Joubert et al.
HUMAN MOLECULAR GENETICS (2013)
Intrapleural Administration of AAV9 Improves Neural and Cardiorespiratory Function in Pompe Disease
Darin J. Falk et al.
MOLECULAR THERAPY (2013)
Pompe Disease: Early Diagnosis and Early Treatment Make a Difference
Yin-Hsiu Chien et al.
PEDIATRICS AND NEONATOLOGY (2013)
Preclinical Toxicology and Biodistribution Studies of Recombinant Adeno-Associated Virus 1 Human Acid α-Glucosidase
Thomas J. Conlon et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients
Anna Chiara Nascimbeni et al.
AUTOPHAGY (2012)
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models
James J. Dowling et al.
DISEASE MODELS & MECHANISMS (2012)
Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice
Kai Qiu et al.
MOLECULAR THERAPY (2012)
Icy: an open bioimage informatics platform for extended reproducible research
Fabrice de Chaumont et al.
NATURE METHODS (2012)
Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus
Aline Huguet et al.
PLOS GENETICS (2012)
Pompe disease gene therapy
Barry J. Byrne et al.
HUMAN MOLECULAR GENETICS (2011)
Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)
Friedrich Metzger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Electrical Impedance as a Novel Biomarker of Myotube Atrophy and Hypertrophy
Sergey Rakhilin et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
The effect of subacute denervation on the electrical anisotropy of skeletal muscle: Implications for clinical diagnostic testing
Mohammad A. Ahad et al.
CLINICAL NEUROPHYSIOLOGY (2010)
Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease
Cathryn S. Mah et al.
MOLECULAR THERAPY (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Fiber Type Conversion by PGC-1α Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle
Shoichi Takikita et al.
PLOS ONE (2010)
Acute Progression of Neuromuscular Findings in Infantile Pompe Disease
T. Andrew Burrow et al.
PEDIATRIC NEUROLOGY (2010)
Impaired Synaptic Vesicle Release and Immaturity of Neuromuscular Junctions in Spinal Muscular Atrophy Mice
Lingling Kong et al.
JOURNAL OF NEUROSCIENCE (2009)
Diagnostic criteria for late-onset (childhood and adult) pompe disease
MUSCLE & NERVE (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Neural deficits contribute to respiratory insufficiency in Pompe disease
Lara R. DeRuisseau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adulte Form des Mangels an saurer Maltase unter dem Bild einer progressiven spinalen Muskelatrophie*
D. Pongratz et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice
Robin J. Ziegler et al.
HUMAN GENE THERAPY (2008)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Late onset Pompe disease:: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients
Wolfgang Muller-Felber et al.
NEUROMUSCULAR DISORDERS (2007)
Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors
Cathryn Mah et al.
MOLECULAR THERAPY (2007)
Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice
Jonathan D. Schertzer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease
Priya Sunil Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
Enzyme replacement therapy in classical infantile Pompe disease: Results of a ten-month follow-up study
L Klinge et al.
NEUROPEDIATRICS (2005)
Long term intravenous treatment of Pompe disease with recombinant human α-glucosidase from milk
JMP Van den Hout et al.
PEDIATRICS (2004)
Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury
C Dellorusso et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2001)